+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Metal Finishing Chemicals Market Size, Share & Trends Analysis Report By Product (Plating Chemicals, Conversion Coatings, Cleaning Chemicals), By Process, By Application, And Segment Forecasts, 2019 - 2025

  • ID: 4753460
  • Report
  • May 2021
  • Region: Global
  • Grand View Research

FEATURED COMPANIES

  • 3D Biomatrix
  • 4titude
  • Allergan
  • Matricel GmbH
  • Merck KGaA
  • Nanofiber Solutions
The global scaffold technology market size is expected to reach USD 2.1 billion by 2028. The market is expected to expand at a CAGR of 8.4% from 2021 to 2028. The market growth can be primarily attributed to the growing popularity of bioprinting for mimicking the tissue microenvironment in printed 3D tissue models. The need to expand the horizon of multidisciplinary research areas has supplemented the adoption of scaffold technologies in 3D printed models.



For instance, in October 2021, researchers integrated novel biomaterial scaffold-guided regeneration for multiple periodontal tissues. The incorporation of advanced imaging modalities along with 3D printing has facilitated non-invasive tracking of in vivo degradation of scaffolds. The advent of such technologies is expected to propel the adoption of scaffolds in tissue engineering and regeneration, thereby providing considerable momentum to market growth.

Additionally, the development of novel diagnostic and therapeutic strategies such as tissue engineering, regenerative medicine, have been largely favored in the wake of the pandemic outbreak of SARS-COV-2 infection. Expanding research activities in the field of tissue engineering have led to the advent of scaffold-based vaccine systems, which have the potential tocombatCOVID-19. Progress in this area is expected to cause a surge in the adoption of advanced medical technologies in COVID-19 vaccine development and research.

Furthermore, researchers are proactively using in vitro human lung tissue models developed using tissue-engineered for the understanding of mechanisms of the infection and host-pathogen interface. The application of tissue engineering is used for culturing multiple pulmonary cell lines, improving the relevance of in vitro models, and the use of 3D scaffolds that mimic native pulmonary architecture.

Scaffold Technology Market Report Highlights
  • The hydrogels segment dominated the market in terms of revenue in 2020 owing to advantages such as high biocompatibility, thermal reversibility, and strong cellular activities, contributing to its increasing adoption rate.
  • The nanofiber-based scaffolds segment is expected to witness lucrative growth owing to the growing advancements such as 3D molding for developing 3D nanofiber membranes.
  • The stem cell therapy, regenerative medicine, and tissue engineering segment held the largest revenue share in 2020.
  • This growth is attributed to the expanding adoption of scaffolds in the aesthetic procedure, wound healing, periodontology, and colorectal surgeries.
  • The drug discovery segment is expected to witness the fastest CAGR over the forecast period.
  • Scaffolds play a vital role in the elucidation of molecular reasons for the activity of drug candidate in toxicity screening procedures, which is expected to impact the growth of medical technology in this segment.
  • The orthopedics, musculoskeletal, and spine segment held a substantial market share in 2020 due to an increase in the popularity of regenerative medicines.
  • Regenerative medicines can offer various lower risk substitutes to allograft surgery, thereby supplementing the adoption of the technology in this segment.
  • The biotechnology and pharmaceutical industries segment dominated the market in terms of revenue share in 2020 owing to their high engagement in new drug discovery and development.
  • North America held the largest revenue share in 2020. Growth in this region is owing to the presence of key players and extensive R&D activities.
  • Companies operating in the market are entering into partnership for developing 3D cell culture models.
  • For instance, in March 2021, PELOBiotech GmbH entered in partnership with Rigenerand SRL for developing 3D Cell Culture models. The company distributed its VITVO handheld bioreactor which is integrated with a scaffold for establishing in vitro 3D cell culture model that is used in pre-clinical investigations and research applications.

This report will be delivered within 1-3 business days.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3D Biomatrix
  • 4titude
  • Allergan
  • Matricel GmbH
  • Merck KGaA
  • Nanofiber Solutions
Chapter 1 Scaffold Technology: Methodology and Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 Internal database
1.1.3 Secondary sources:
1.1.4 Third party perspective:
1.1.5 Primary research:
1.2 Data Analysis
1.3 Market Formulation & Validation
1.4 Region Wise Market Calculation & Scope
1.4.1 Market scope: By application
1.4.2 Region wise market: Base estimates
1.4.3 Global market: CAGR calculation
1.4.4 Region based segment share calculation

Chapter 2 Scaffold Technology Market: Executive Summary
2.1 Market Summary, 2020

Chapter 3 Scaffold Technology: Market Variables, Trends, & Scope
3.1 Scaffold technology Market: Segment Outlook, 2017 - 2028
3.1.1 Market driver analysis
3.1.1.1 Increasing demand for 3D cellular models in translational research
3.1.1.2 Increasing demand for body reconstruction procedures and tissue engineering
3.1.1.3 Advancements in scaffold technology
3.1.2 Market restraint analysis
3.1.2.1 Introduction of scaffold-free technology for 3D cell culture
3.1.2.2 Lack of consistency in generated results
3.2 Penetration & Growth Prospect Mapping for Type, 2020
3.3 Scaffold Technology Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s

Chapter 4 Scaffold Technology Market: Type Business Analysis
4.1 Scaffold Technology Market: Type Movement Analysis, 2020 & 2028
4.2 Hydrogels
4.2.1 Global scaffold technology market for hydrogels, 2017 - 2028 (USD Million)
4.2.2 Hydrogels, by application
4.2.2.1 Wound healing
4.2.2.1.1 Global hydrogels market for wound healing, 2017 - 2028 (USD Million)
4.2.3.1 3D bioprinting
4.2.3.1.1 Global hydrogels market for 3D bioprinting, 2017 - 2028 (USD Million)
4.2.4.1 Immunomodulation
4.2.4.1.1 Global hydrogels market for immunomodulation, 2017 - 2028 (USD Million)
4.3 Polymeric Scaffolds
4.3.1 Global scaffold technology market for polymeric scaffolds, 2017 - 2028 (USD Million)
4.4 Micropatterned Surface Microplates
4.4.1 Global scaffold technology market for micropatterned surface microplates, 2017 - 2028 (USD Million)
4.5 Nanofiber-based Scaffolds
4.5.1 Global scaffold technology market for nanofiber-based scaffolds, 2017 - 2028 (USD Million)

Chapter 5 Scaffold Technology Market: Application Business Analysis
5.1 Scaffold Technology Market: Application Movement Analysis, 2020 & 2028
5.2 Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
5.2.1 Cell encapsulations for regenerative medicine
5.2.2 Global scaffold technology market for stem cell therapy, regenerative medicine, & tissue engineering, 2017 - 2028 (USD Million)
5.3 Drug Discovery
5.3.1 Global scaffold technology market for drug discovery, 2017 - 2028 (USD Million)
5.4 Others
5.4.1 Global scaffold technology market for others, 2017 - 2028 (USD Million)

Chapter 6 Scaffold Technology Market: Disease Type Business Analysis
6.1 Scaffold Technology Market: Disease Type Movement Analysis, 2020 & 2028
6.2 Orthopedics, Musculoskeletal, & Spine
6.2.1 Global scaffold technology market for orthopedics, musculoskeletal, & spine, 2017 - 2028 (USD Million)
6.3 Cancer
6.3.1 Analysis of extracellular matrix (ECM) scaffolds and nanotechnology-based strategies for cancer diagnosis and prognosis
6.3.2 Global scaffold technology market for cancer, 2017 - 2028 (USD Million)
6.4 Skin & Integumentary
6.4.1 Global scaffold technology market for skin & integumentary, 2017 - 2028 (USD Million)
6.5 Dental
6.5.1 Strategies for developing new smart tissue engineering scaffolds for dentine‐pulp complex regeneration
6.5.2 Global scaffold technology market for dental, 2017 - 2028 (USD Million)
6.6 Cardiology & Vascular
6.6.1 Global scaffold technology market for cardiology & vascular, 2017 - 2028 (USD Million)
6.7 Neurology
6.7.1 Global scaffold technology market for neurology, 2017 - 2028 (USD Million)
6.8 Urology
6.8.1 Global scaffold technology market for urology, 2017 - 2028 (USD Million)
6.9 Gastrointestinal Disorders (GI) & Gynecology
6.9.1 Global scaffold technology market for GI& gynecology, 2017 - 2028 (USD Million)
6.10 Others
6.10.1 Global scaffold technology market for other disease types, 2017 - 2028 (USD Million)

Chapter 7 Scaffold Technology Market: End-use Business Analysis
7.1 Scaffold Technology Market: End-use Movement Analysis, 2020 & 2028
7.2 Biotechnology and Pharmaceutical Industries
7.2.1 Global scaffold technology market for biotechnology and pharmaceutical industries, 2017 - 2028 (USD Million)
7.3 Research Laboratories and Institutes
7.3.1 Global scaffold technology market for research laboratories and institutes, 2017 - 2028 (USD Million)
7.4 Hospitals and Diagnostic Centers
7.4.1 Global scaffold technology market for hospitals and diagnostic centers, 2017 - 2028 (USD Million)
7.5 Others
7.5.1 Global scaffold technology market for others, 2017 - 2028 (USD Million)

Chapter 8 Scaffold Technology Market: Regional Business Analysis
8.1 Scaffold Technology Market: Regional Movement Analysis, 2020 & 2028
8.2 North America
8.2.1 North America scaffold technology market, 2017 - 2028 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. scaffold technology market, 2017 - 2028 (USD Million)
8.2.3 Canada
8.2.3.1 Canada scaffold technology market, 2017 - 2028 (USD Million)
8.3 Europe
8.3.1 Europe scaffold technology market, 2017 - 2028 (USD Million)
8.3.2 Germany
8.3.2.1 Germany scaffold technology market, 2017 - 2028 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. scaffold technology market, 2017 - 2028 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific scaffold technology market, 2017 - 2028 (USD Million)
8.4.2 Japan
8.4.2.1 Japan scaffold technology market, 2017 - 2028 (USD Million)
8.4.3 China
8.4.3.1 China scaffold technology market, 2017 - 2028 (USD Million)
8.5 Latin America
8.5.1 Latin America scaffold technology market, 2017 - 2028 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil scaffold technology market, 2017 - 2028 (USD Million)
8.6 Middle East and Africa (MEA)
8.6.1 MEA scaffold technology market, 2017 - 2028 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa scaffold technology market, 2017 - 2028 (USD Million)

Chapter 9 Scaffold Technology Market: Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Merck KGaA
9.3.1.1 Company overview
9.3.1.2 Sigma-Aldrich, Inc.
9.3.1.2.1 Company overview
9.3.1.3 Merck Millipore
9.3.1.3.1 Company overview
9.3.1.4 Financial performance
9.3.1.5 Product benchmarking
9.3.1.6 Strategic initiatives
9.3.2 Thermo Fisher Scientific, Inc.
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Becton, Dickinson And Company
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.4 3D Biotek LLC
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Molecular Matrix, Inc.
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 REPROCELL, Inc.
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Xanofi
9.3.7.1 Company overview
9.3.7.2 Product benchmarking
9.3.7.3 Strategic initiatives
9.3.8 Tecan Trading AG
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Matricel GmbH
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Pelobiotech
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.11 Corning Incorporated
9.3.11.1 Company overview
9.3.11.2 Financial performance
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
9.3.12 Akron Biotech
9.3.12.1 Company overview
9.3.12.2 Financial performance
9.3.12.3 Product benchmarking
9.3.12.4 Strategic initiatives
9.3.13 4titude
9.3.13.1 Company overview
9.3.13.2 Financial performance
9.3.13.3 Product benchmarking
9.3.14 3D Biomatrix
9.3.14.1 Company overview
9.3.14.2 Product benchmarking
9.3.15 Nanofiber Solutions
9.3.15.1 Company overview
9.3.15.2 Financial performance
9.3.15.3 Product benchmarking
9.3.15.4 Strategic initiatives
9.3.16 NuVasive, Inc.
9.3.16.1 Company overview
9.3.16.2 Financial performance
9.3.16.3 Product benchmarking
9.3.16.4 Strategic initiatives
9.3.17 Avacta Life Sciences Limited
9.3.17.1 Company overview
9.3.17.2 Financial performance
9.3.17.3 Product benchmarking
9.3.17.4 Strategic initiatives
9.3.18 Medtronic
9.3.18.1 Company overview
9.3.18.2 Financial performance
9.3.18.3 Product benchmarking
9.3.18.4 Strategic initiatives
9.3.19 Allergan
9.3.19.1 Company overview
9.3.19.2 LifeCell Corporation
9.3.19.2.1 Company overview
9.3.19.3 Financial performance
9.3.19.4 Product benchmarking
9.3.19.5 Strategic initiatives
9.3.20 Vericel Corporation
9.3.20.1 Company overview
9.3.20.2 Financial performance
9.3.20.3 Product benchmarking
9.3.20.4 Strategic initiatives

List of Tables
Table 1 Country share estimation
Table 2 Comparative performance analysis of different 3D cell culture techniques
Table 3 Comparative performance analysis of commercially available scaffolds-based 3D culture systems
Table 4 Classification of the scaffold fabrication technologies
Table 5 Comparison of different drug loading strategies for chitosan-based hydrogels
Table 6 Comparison of commonly used non-functionalized bioinks
Table 7 List of some of the commercially available polymeric scaffold products
Table 8 Hydrogels used for drug delivery
Table 9 Bioactive components of ECM scaffolds that play a role in constructive tissue remodeling outcomes
Table 10 ECM-derived molecules in cancer diagnosis
Table 11 Biomaterials‐based scaffolds for regeneration of the dentin‐pulp complex
Table 12 Scaffolds for neurology
Table 13 Scaffolds used as tubular urethral substitutes
Table 14 Preclinical and human studies evaluating the use of ECM bioscaffolds to repair GI tissue
Table 15 Biomaterials used for corneal bioengineering
Table 16 North America scaffold technology market estimates & forecasts, by type, 2017-2028 (USD Million)
Table 17 North America hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 18 North America scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 19 North America scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 20 North America scaffold technology market estimates & forecasts, by enduse, 2017 - 2028 (USD Million)
Table 21 U.S. scaffold technology market estimates & forecasts, by type, 2017-2028 (USD Million)
Table 22 U.S. hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 23 U.S. scaffold technology market estimates & forecasts, by application, 2017-2028(USD Million)
Table 24 U.S. scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 25 U.S. scaffold technology market estimates & forecasts, by enduse, 2017 - 2028 (USD Million)
Table 26 Canada scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 27 Canada hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 28 Canada scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 29 Canada scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 30 Canada scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
Table 31 Europe scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 32 Europe hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 33 Europe scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 34 Europe scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 35 Europe scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
Table 36 U.K. scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 37 U.K. hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 38 U.K. scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 39 U.K. scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 40 U.K. scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
Table 41 Germany scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 42 Germany hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 43 Germany scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 44 Germany scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 45 Germany scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
Table 46 Asia Pacific scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 47 Asia Pacific hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 48 Asia Pacific scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 49 Asia Pacific scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 50 Asia Pacific scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
Table 51 Japan scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 52 Japan hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 53 Japan scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 54 Japan scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 55 Japan scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
Table 56 China scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 57 China hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 58 China scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 59 China scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 60 China scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
Table 61 Latin America scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 62 Latin America hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 63 Latin America scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 64 Latin America scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 65 Latin America scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
Table 66 Brazil scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 67 Brazil hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 68 Brazil scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 69 Brazil scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 70 Brazil scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
Table 71 MEA scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 72 MEA hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 73 MEA scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 74 MEA scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 75 MEA scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
Table 76 South Africa scaffold technology market estimates & forecasts, by type, 2017 - 2028 (USD Million)
Table 77 South Africa hydrogel scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 78 South Africa scaffold technology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
Table 79 South Africa scaffold technology market estimates & forecasts, by disease type, 2017 - 2028 (USD Million)
Table 80 South Africa scaffold technology market estimates & forecasts, by end use, 2017 - 2028 (USD Million)

List of Figures
Fig. 1 Market summary (USD Million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain-based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market segmentation & scope
FIG. 9 Market trends & outlook
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Classification of regenerative medicine on the basis of usage of scaffolds
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Challenges associated with the consistency of implications of scaffold technology
FIG. 14 Penetration & growth prospect mapping for type, 2020
FIG. 15 SWOT Analysis, by factor (political & legal, economic and technological)
FIG. 16 Porter’s Five Forces Analysis
FIG. 17 Scaffold technology market: Type outlook key takeaways
FIG. 18 Scaffold technology market: Type movement analysis
FIG. 19 Scaffold technology market for hydrogels, 2017 - 2028 (USD Million)
FIG. 20 Global polymeric hydrogels: Advantages and disadvantages
FIG. 21 Characteristics of chitosan-based hydrogels
FIG. 22 Application of chitosan-based hydrogel dressings
FIG. 23 Global hydrogels market for wound healing, 2017 - 2028 (USD Million)
FIG. 24 Characteristics of bioinks
FIG. 25 Global hydrogels market for 3D bioprinting, 2017 - 2028 (USD Million)
FIG. 26 Global hydrogels market for immunomodulation, 2017 - 2028 (USD Million)
FIG. 27 Global scaffold technology market for polymeric scaffolds, 2017 - 2028 (USD Million)
FIG. 28 Global scaffold technology market for micropatterned surface microplates, 2017 - 2028 (USD Million)
FIG. 29 Global scaffold technology market for nanofiber-based scaffolds, 2017 - 2028 (USD Million)
FIG. 30 Scaffold technology market: Application outlook key takeaways
FIG. 31 Scaffold technology market: Application movement analysis
FIG. 32 Global scaffold technology market for stem cell therapy, regenerative medicine, & tissue engineering, 2017 - 2028 (USD Million)
FIG. 33 Global scaffold technology market for drug discovery, 2017 - 2028 (USD Million)
FIG. 34 Global scaffold technology market for others, 2017 - 2028 (USD Million)
FIG. 35 Scaffold technology market: Disease type outlook key takeaways
FIG. 36 Scaffold technology market: Disease type movement analysis
FIG. 37 Global scaffold technology market for orthopedics, musculoskeletal, & spine, 2017 - 2028 (USD Million)
FIG. 38 Global scaffold technology market for cancer, 2017 - 2028 (USD Million)
FIG. 39 Global scaffold technology market for skin & integumentary, 2017 - 2028 (USD Million)
FIG. 40 Strategies for developing new smart tissue engineering scaffolds for dentine‐pulp complex regeneration
FIG. 41 Global scaffold technology market for dental, 2017 - 2028 (USD Million)
FIG. 42 Global scaffold technology market for cardiology & vascular, 2017 - 2028 (USD Million)
FIG. 43 Global scaffold technology market for neurology, 2017 - 2028 (USD Million)
FIG. 44 Applications of silk fibroin in urology
FIG. 45 Global scaffold technology market for urology, 2017 - 2028 (USD Million)
FIG. 46 Global scaffold technology market for GI & gynecology, 2017 - 2028 (USD Million)
FIG. 47 Global scaffold technology market for other disease types, 2017 - 2028 (USD Million)
FIG. 48 Scaffold technology market: End-use outlook key takeaways
FIG. 49 Scaffold technology market: End-use movement analysis
FIG. 50 Global scaffold technology market for biotechnology and pharmaceutical industries, 2017 - 2028 (USD Million)
FIG. 51 Global scaffold technology market for research laboratories and institutes, 2017 - 2028 (USD Million)
FIG. 52 Global scaffold technology market for hospitals and diagnostic centers, 2017 - 2028 (USD Million)
FIG. 53 Global scaffold technology market for others, 2017 - 2028 (USD Million)
FIG. 54 Regional marketplace: Key takeaway
FIG. 55 Scaffold technology regional outlook, 2020&2028
FIG. 56 North America scaffold technology market, 2017 - 2028 (USD Million)
FIG. 57 Number of transplants conducted in the U.S., 2018 by organs
FIG. 58 U.S. scaffold technology market, 2017 - 2028 (USD Million)
FIG. 59 Canada scaffold technology market, 2017 - 2028 (USD Million)
FIG. 60 Europe scaffold technology market, 2017 - 2028 (USD Million)
FIG. 61 Germany scaffold technology market, 2017 - 2028 (USD Million)
FIG. 62 U.K. scaffold technology market, 2017 - 2028 (USD Million)
FIG. 63 Asia Pacific scaffold technology market, 2017 - 2028 (USD Million)
FIG. 64 Japan scaffold technology market, 2017 - 2028 (USD Million)
FIG. 65 China scaffold technology market, 2017 - 2028 (USD Million)
FIG. 66 Latin America scaffold technology market, 2017 - 2028 (USD Million)
FIG. 67 Brazil scaffold technology market, 2017 - 2028 (USD Million)
FIG. 68 MEA scaffold technology market, 2017 - 2028 (USD Million)
FIG. 69 South Africa scaffold technology market, 2017 - 2028 (USD Million)
FIG. 70 Strategy framework
FIG. 71 Market participant categorization
Note: Product cover images may vary from those shown
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson And Company
  • 3D Biotek LLC
  • Molecular Matrix, Inc.
  • REPROCELL, Inc.
  • Xanofi
  • Tecan Trading AG
  • Matricel GmbH
  • Pelobiotech
  • Corning Incorporated
  • Akron Biotech
  • 4titude
  • 3D Biomatrix
  • Nanofiber Solutions
  • NuVasive, Inc.
  • Avacta Life Sciences Limited
  • Medtronic
  • Allergan
  • Vericel Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll